Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > ActiveCare, Inc. Announces Strategic Relationship With Vista Therapeutics, Inc. in Developing Nano B

Abstract:
ActiveCare, Inc. (OTC Bulletin Board: ACAR) and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly.

ActiveCare, Inc. Announces Strategic Relationship With Vista Therapeutics, Inc. in Developing Nano B

Posted on June 21st, 2010

These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare. "Through the use of Vista's nanotechnology, which allows extreme miniaturization combined with continuous monitoring, we will be able to monitor continuously at our CareCenter specific drug and disease indicators, allowing us to react quickly to a pending acute event. It is ActiveCare's goal to combine Vista's biosensors into the company's ActiveOne+ watch which is worn by the senior and transmits back to ActiveCare's 24/7 CareCenter. This technology could truly revolutionize how we care for our senior population."

Vista Therapeutics specializes in developing leading nanotechnology. Through exclusive license agreements with Nanosys, Inc. and Harvard University, Vista is developing and marketing nanowire-based biosensors that detect and can take measurements of over 250 indicators or markers. The strategic agreement between Vista and ActiveCare is to integrate Vista's technology into ActiveCare's products ultimately providing real-time accurate medical information.

Vista Therapeutics has some of the world's foremost scientists in nanotechnologies, including Spencer Farr, PhD, its CEO and Chairman. Dr. Farr was a faculty member at Harvard and MIT and has been an innovator in the toxicology and drug development industry. The Chief Scientific Officer for Vista Therapeutics is Charles Lieber, PhD. Dr. Lieber is currently a professor at Harvard's Department of Chemistry and Chemical Biology and is widely held as the foremost pioneer in the development of nanowires, together with the demonstration of applications of those materials in nanoelectronics, nanocomputing, biological and chemical sensing, neurobiology and nanophotonics. Dr. Lieber has published over 300 papers in peer-reviewed journals and is the principal inventor on more than 35 patents.

The terms of the strategic agreement between Vista and ActiveCare call for ActiveCare to make an equity investment in Vista Therapeutics and to pay a fee for the development of products utilizing Vista Therapeutic's Nano Biosensor Technology. In addition, Dr. Farr has agreed to serve on ActiveCare's advisory board to help identify new products and services for ActiveCare.

As part of the strategic agreement, ActiveCare will have exclusive use of the Vista Therapeutics' technology in the elderly market (excluding hospitals, for which ActiveCare will also have the right to acquire an exclusive sub-license).

Mr. Dalton concluded, "We are extremely pleased to have such a strategic partner as Vista Therapeutics. The caliber of scientific development and technologies that Vista Therapeutics can bring to ActiveCare allows the company to fulfill its mission of helping the elderly age comfortably in their own homes."

Safe Harbor Statement


This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, including future growth and earnings opportunities of the Company. Examples of forward-looking statements in this release include references to the results of operations during future periods, the success of implementing future phases of the company's business plan, and the launch of new products. Actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including the Company's ability to retain and to promptly satisfy current backorders and other economic, competitive, governmental, technological, regulatory, manufacturing and marketing risks associated with the Company' business and financial plans. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in the Company's most recent filings with the Securities and Exchange Commission.

ActiveCare(TM), CareCenter(TM) and CareSpecialist(TM) are trademarks of ActiveCare, Inc.

####

About ActiveCare, Inc.
ActiveCare, Inc. (website at www.activecare.com) is a biotelematic technology company specializing in creating advanced products and services that help seniors manage and control their health and well being, while reducing overall costs to the healthcare industry.

Through ActiveCare's telematic and biosensor technologies, it can provide "peace of mind" to both the care provider and the senior and ensures that the senior's health needs are being met. Through ActiveCare's CareCenter(TM), the member's medical data are stored including doctors, medications and care providers. In addition through its telematic technologies, it constantly knows where the member is located in case of emergency and at the touch of a button is in immediate contact with a CareSpecialist(TM) who can then aid the elderly with their daily and medical problems.

About Vista Therapeutics, Inc.
Vista Therapeutics, Inc. (website at www.vistatherapeutics.org) is a technology company that integrates advances in materials science with biotechnology to create new biomolecule measurement and monitoring systems. It specializes in measurement of biomarkers of organ injury, damage or disease.

For more information, please click here

Contacts:
investor/media relations
801-974-9474

Copyright © PR-Canada.net

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nanofiltration Membrane Market 2015 - Global Industry Survey, Analysis, Size, Share, Outlook and Forecast to 2020 July 31st, 2015

Nanozirconia Market 2015 - Global Industry Survey, Analysis, Size, Share, Outlook and Forecast to 2020 July 31st, 2015

Self-Healing Nano Anti-rust Coatings Market 2015 - Global Industry Survey, Analysis, Size, Share, Outlook and Forecast to 2020 July 31st, 2015

Nano Spray Instrument Market 2015 - Global Industry Survey, Analysis, Size, Share, Outlook and Forecast to 2020 July 31st, 2015

Nanomedicine

Heating and cooling with light leads to ultrafast DNA diagnostics July 31st, 2015

European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award: The Award to be presented at BIO-Europe conference in Munich, November 2015 July 30th, 2015

Take a trip through the brain July 30th, 2015

Sol-gel capacitor dielectric offers record-high energy storage July 30th, 2015

Sensors

Controlling Dynamic Behavior of Carbon Nanosheets in Structures Made Possible July 30th, 2015

Non-Enzyme Sensor Determines Level of Blood Sugar July 29th, 2015

American Chemical Society expands reach to include rapidly emerging area of sensor science July 25th, 2015

UT Dallas nanotechnology research leads to super-elastic conducting fibers July 24th, 2015

Announcements

Nano Spray Instrument Market 2015 - Global Industry Survey, Analysis, Size, Share, Outlook and Forecast to 2020 July 31st, 2015

Nanocellulose Market 2015 - Global Industry Survey, Analysis, Size, Share, Outlook and Forecast to 2020 July 31st, 2015

Heating and cooling with light leads to ultrafast DNA diagnostics July 31st, 2015

Theoretical Physicists at Freie Universitšt Berlin Develop New Insights into Interface between Classical and Quantum Worlds July 31st, 2015

Personal Care

Nanomaterials In Cosmetic And Personal Care Market 2015 - Global Industry Survey, Analysis, Size, Share, Outlook and Forecast to 2020 July 31st, 2015

Make mine a decaf: Breakthrough in knowledge of how nanoparticles grow: University of Leicester and CNRS researchers observe how nanoparticles grow when exposed to helium July 23rd, 2015

Environmentally friendly lignin nanoparticle 'greens' silver nanobullet to battle bacteria July 13th, 2015

Mesoporous Particles for the Development of Drug Delivery System Safe to Human Bodies June 9th, 2015

Nanobiotechnology

Heating and cooling with light leads to ultrafast DNA diagnostics July 31st, 2015

European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award: The Award to be presented at BIO-Europe conference in Munich, November 2015 July 30th, 2015

New computer model could explain how simple molecules took first step toward life: Two Brookhaven researchers developed theoretical model to explain the origins of self-replicating molecules July 28th, 2015

Spintronics: Molecules stabilizing magnetism: Organic molecules fixing the magnetic orientation of a cobalt surface/ building block for a compact and low-cost storage technology/ publication in Nature Materials July 25th, 2015

Alliances/Trade associations/Partnerships/Distributorships

Liquipel Debuts Eyesight-Saving ION-Glass Blue Light Protection for iPhones and Androids at RadioShack Stores Nationwide: Liquipel's Unique Protective Screen, Available at RadioShack, Cuts Harmful Blue Light Implicated in Macular Degeneration by 10x July 28th, 2015

Dais Analytic's Business Affiliate in China Announces Ten-Year Strategic Energy Efficiency Business Arrangement With COFCO: Dais Beijing to Perform Feasibility Study on Over 80 Buildings to Improve Efficiencies as Part of Overall Hotel Energy-Savings Project July 23rd, 2015

Leti and Diabeloop Project Aims at Developing Artificial Pancreas for Diabetes Treatment July 22nd, 2015

Imec and Panasonic Demonstrate Breakthrough RRAM Cell July 16th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project